Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ROLLINS SA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Clark, DJ; Cleman, MW; Pfau, SE; Rollins, SA; Ramahi, TM; Mayer, C; Caulin-Glaser, T; Daher, E; Kosiborod, M; Bell, L; Setaro, JF
      Serum complement activation in congestive heart failure

      AMERICAN HEART JOURNAL
    2. Rollins, SA; Johnson, KK; Li, L; Birks, C; Matis, LA; Rother, RP
      Role of porcine P-selectin in complement-dependent adhesion of human leukocytes to porcine endothelial cells

      TRANSPLANTATION
    3. Collard, CD; Vakeva, A; Morrissey, MA; Agah, A; Rollins, SA; Reenstra, WR; Buras, JA; Meri, S; Stahl, GL
      Complement activation after oxidative stress - Role of the lectin complement pathway

      AMERICAN JOURNAL OF PATHOLOGY
    4. Wang, H; Rollins, SA; Gao, ZH; Garcia, B; Zhang, Z; Xing, JJ; Li, L; Kellersmann, R; Matis, LA; Zhong, R
      Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model

      TRANSPLANTATION
    5. Rinder, CS; Rinder, HM; Smith, MJ; Tracey, JB; Fitch, J; Li, L; Rollins, SA; Smith, BR
      Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    6. COLLARD CD; AGAH A; MORSE DS; ROLLINS SA; MATIS LA; STAHL GL
      REOXYGENATION OF HYPOXIC HUVECS IN HUMAN SERA AUGMENTS NUCLEAR NF-KAPPA-B TRANSLOCATION AND EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1(VCAM-1) - INHIBITION WITH ANTI-HUMAN C5 THERAPY

      Molecular immunology
    7. ROLLINS SA; FITCH JCK; SHERNAN S; RINDER CS; RINDER HM; SMITH BR; COLLARD CD; STAHL GL; ALFORD BL; LI L; MATIS LA
      ANTI-C5 SINGLE-CHAIN ANTIBODY THERAPY BLOCKS COMPLEMENT AND LEUKOCYTEACTIVATION AND REDUCES MYOCARDIAL TISSUE-DAMAGE IN CPB PATIENTS

      Molecular immunology
    8. VAKEVA AP; AGAH A; ROLLINS SA; MATIS LA; LI L; STAHL GL
      MYOCARDIAL-INFARCTION AND APOPTOSIS AFTER MYOCARDIAL-ISCHEMIA AND REPERFUSION - ROLE OF THE TERMINAL COMPLEMENT COMPONENTS AND INHIBITION BY ANTI-C5 THERAPY

      Circulation
    9. FITCH JCK; ELEFTERIADES JA; MATIS LA; EVANS MJ; RINDER HM; ROLLINS SA; ALFORD BL; HINES RL
      SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS

      Journal of the American College of Cardiology
    10. VAKEVA A; ROLLINS SA; MATIS LA; STAHL GL
      MONOCLONAL-ANTIBODY TO C5 INHIBITS C5A AND C5B-9 GENERATION WITHOUT INHIBITION OF C3 CLEAVAGE AND SIGNIFICANTLY LIMITS MYOCARDIAL-ISCHEMIA AND REPERFUSION-INDUCED TISSUE-DAMAGE

      Journal of the American College of Cardiology
    11. ROLLINS SA; BIRKS CW; SETTER E; SQUINTO SP; ROTHER RP
      RETROVIRAL VECTOR PRODUCER CELL-KILLING IN HUMAN SERUM IS MEDIATED BYNATURAL ANTIBODY AND COMPLEMENT - STRATEGIES FOR EVADING THE HUMORAL IMMUNE-RESPONSE

      Human gene therapy
    12. SANDRIN MS; FODOR WL; COHNEY S; MOUHTOURIS E; OSMAN N; ROLLINS SA; SQUINTO SP; MCKENZIE IFC
      REDUCTION OF THE MAJOR PORCINE XENOANTIGEN GA1-ALPHA(1,3)GAL BY EXPRESSION OF ALPHA(1,2)FUCOSYLTRANSFERASE

      Xenotransplantation
    13. THOMAS TC; ROLLINS SA; ROTHER RP; GIANNONI MA; HARTMAN SL; ELLIOTT EA; NYE SH; MATIS LA; SQUINTO SP; EVANS MJ
      INHIBITION OF COMPLEMENT ACTIVITY BY HUMANIZED ANTI-C5 ANTIBODY AND SINGLE-CHAIN FV

      Molecular immunology
    14. KROSHUS TJ; BOLMAN RM; DALMASSO AP; ROLLINS SA; GUILMETTE ER; WILLIAMS BL; SQUINTO SP; FODOR WL
      EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX-VIVO XENOGENEIC PERFUSION MODEL

      Transplantation
    15. WANG Y; HU QL; MADRI JA; ROLLINS SA; CHODERA A; MATIS LA
      AMELIORATION OF LUPUS-LIKE AUTOIMMUNE-DISEASE IN NZB WF1 MICE AFTER TREATMENT WITH A BLOCKING MONOCLONAL-ANTIBODY SPECIFIC FOR COMPLEMENT COMPONENT C5/

      Proceedings of the National Academy of Sciences of the United Statesof America
    16. FITCH JCK; ELEFTERIADES JA; RINDER JM; MATIS LA; EVANS MJ; ROLLINS SA; ALFORD BL; HINES RL
      SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS

      Blood
    17. MATIS LA; ROLLINS SA
      COMPLEMENT SPECIFIC ANTIBODIES - DESIGNING NOVEL ANTIINFLAMMATORIES

      Nature medicine
    18. SANDRIN MS; FODOR WL; MOUHTOURIS E; OSMAN N; COHNEY S; ROLLINS SA; GUILMETTE ER; SETTER E; SQUINTO SP; MCKENZIE IFC
      ENZYMATIC REMODELING OF THE CARBOHYDRATE SURFACE OF A XENOGENIC CELL SUBSTANTIALLY REDUCES HUMAN-ANTIBODY BINDING AND COMPLEMENT-MEDIATED CYTOLYSIS

      Nature medicine
    19. ROTHER RP; SQUINTO SP; MASON JM; ROLLINS SA
      PROTECTION OF RETROVIRAL VECTOR PARTICLES IN HUMAN BLOOD THROUGH COMPLEMENT INHIBITION

      Human gene therapy
    20. ROLLINS SA; SQUINTO SP; MASON JM; ROTHER RP
      PROTECTION OF RETROVIRAL VECTOR PARTICLES VIA COMPLEMENT INHIBITION -A NOVEL STRATEGY FOR IN-VIVO GENE-THERAPY

      Journal of cellular biochemistry
    21. ROTHER RP; SPRINGHORN JP; FODO WL; SQUINTO SP; ROLLINS SA
      ANTIBODY-DEPENDENT INACTIVATION OF RETROVIRAL VECTOR PARTICLES BY HUMAN SERUM MEDIATED BY ANTI-ALPHA-GALACTOSYL NATURAL ANTIBODY

      Journal of cellular biochemistry
    22. SQUINTO SP; ROLLINS SA; SPRINGHORN JP; FODOR WL; ROTHER RP
      INJECTABLE RETROVIRAL PARTICLES FOR HUMAN GENE-THERAPY

      Advanced drug delivery reviews
    23. EVANS MJ; ROLLINS SA; WOLFF DW; ROTHER RP; NORIN AJ; THERRIEN DM; GRIJALVA GA; MUELLER JP; NYE SH; SQUINTO SP; WILKINS JA
      IN-VITRO AND IN-VIVO INHIBITION OF COMPLEMENT ACTIVITY BY A SINGLE-CHAIN FV FRAGMENT RECOGNIZING HUMAN C5

      Molecular immunology
    24. FODOR WL; ROLLINS SA; BIANCOCARON S; BURTON WV; GUILMETTE ER; ROTHER RP; ZAVOICO GB; SQUINTO SP
      PRIMATE TERMINAL COMPLEMENT INHIBITOR HOMOLOGS OF HUMAN CD59

      Immunogenetics
    25. KROSHUS TJ; ROLLINS SA; DALMASSO AP; ELLIOTT EA; MATIS LA; SQUINTO SP; BOLMAN RM
      COMPLEMENT INHIBITION WITH AN ANTI-C5 MONOCLONAL-ANTIBODY PREVENTS ACUTE CARDIAC TISSUE-INJURY IN AN EX-VIVO MODEL OF PIG-TO-HUMAN XENOTRANSPLANTATION

      Transplantation
    26. ROLLINS SA; MATIS LA; SPRINGHORN JP; SETTER E; WOLFF DW
      MONOCLONAL-ANTIBODIES DIRECTED AGAINST HUMAN C5 AND C8 BLOCK COMPLEMENT-MEDIATED DAMAGE OF XENOGENEIC CELLS AND ORGANS

      Transplantation
    27. WANG Y; ROLLINS SA; MADRI JA; MATIS LA
      ANTI-C5 MONOCLONAL-ANTIBODY THERAPY PREVENTS COLLAGEN-INDUCED ARTHRITIS AND AMELIORATES ESTABLISHED DISEASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    28. FODOR WL; ROLLINS SA; BIANCOCARON S; ROTHER RP; GUILMETTE ER; BURTON WV; ALBRECHT JC; FLECKENSTEIN B; SQUINTO SP
      THE COMPLEMENT CONTROL PROTEIN HOMOLOG OF HERPESVIRUS SAIMIRI REGULATES SERUM COMPLEMENT BY INHIBITING C3 CONVERTASE ACTIVITY

      Journal of virology
    29. FODOR WL; ROLLINS SA; GUILMETTE ER; SETTER E; SQUINTO SP
      A NOVEL BIFUNCTIONAL CHIMERIC COMPLEMENT INHIBITOR THAT REGULATES C3 CONVERTASE AND FORMATION OF THE MEMBRANE ATTACK COMPLEX

      The Journal of immunology
    30. EVANS MJ; HARTMAN SL; WOLFF DW; ROLLINS SA; SQUINTO SP
      RAPID EXPRESSION OF AN ANTI-HUMAN C5 CHIMERIC FAB UTILIZING A VECTOR THAT REPLICATES IN COS AND 293 CELLS

      Journal of immunological methods
    31. ROTHER RP; FODOR WL; SPRINGHORN JP; BIRKS CW; SETTER E; SANDRIN MS; SQUINTO SP; ROLLINS SA
      A NOVEL MECHANISM OF RETROVIRUS INACTIVATION IN HUMAN SERUM MEDIATED BY ANTI-ALPHA-GALACTOSYL NATURAL ANTIBODY

      The Journal of experimental medicine
    32. RINDER CS; RINDER HM; SMITH BR; FITCH JCK; SMITH MJ; TRACEY JB; MATIS LA; SQUINTO SP; ROLLINS SA
      BLOCKADE OF C5A AND C5B-9 GENERATION INHIBITS LEUKOCYTE AND PLATELET ACTIVATION DURING EXTRACORPOREAL-CIRCULATION

      The Journal of clinical investigation
    33. ROTHER RP; FODOR WL; ROLLINS SA; ALBRECHT JC; SETTER E; FLECKENSTEIN B; SQUINTO SP
      INHIBITION OF COMPLEMENT-MEDIATED CYTOLYSIS BY THE TERMINAL COMPLEMENT INHIBITOR OF HERPESVIRUS SAIMIRI

      The FASEB journal
    34. ROLLINS SA; KENNEDY SP; CHODERA AJ; ELLIOTT EA; ZAVOICO GB; MATIS L
      HUMAN CD2 MEDIATES BINDING AND STIMULATION OF HUMAN T-CELLS BY PORCINE ENDOTHELIUM - LACK OF AUGMENTATION BY RECOMBINANT CD59

      The FASEB journal
    35. SQUINTO SP; FODOR WL; ROLLINS SA; ALBRECHT JC; FLECKENSTEIN B; ROTHER R
      HERPESVIRUS SAIMIRI ENCODES FUNCTIONAL INHIBITORS OF BOTH THE C3 CONVERTASE AND MEMBRANE ATTACK COMPLEX STEPS OF THE COMPLEMENT CASCADE

      Journal of cellular biochemistry
    36. ROLLINS SA; KENNEDY SP; CHODERA AJ; ELLIOTT EA; ZAVOICO GB; MATIS LA
      EVIDENCE THAT ACTIVATION OF HUMAN T-CELLS BY PORCINE ENDOTHELIUM INVOLVES DIRECT RECOGNITION OF PORCINE SLA AND COSTIMULATION BY PORCINE LIGANDS FOR LFA-1 AND CD2

      Transplantation
    37. KENNEDY SP; ROLLINS SA; BURTON WV; SIMS PJ; BOTHWELL ALM; SQUINTO SP; ZAVOICO GB
      PROTECTION OF PORCINE AORTIC ENDOTHELIAL-CELLS FROM COMPLEMENT-MEDIATED CELL-LYSIS AND ACTIVATION BY RECOMBINANT HUMAN CD59

      Transplantation
    38. FODOR WL; WILLIAMS BL; MATIS LA; MADRI JA; ROLLINS SA; KNIGHT JW; VELANDER W; SQUINTO SP
      EXPRESSION OF A FUNCTIONAL HUMAN-COMPLEMENT INHIBITOR IN A TRANSGENICPIG AS A MODEL FOR THE PREVENTION OF XENOGENEIC HYPERACUTE ORGAN REJECTION

      Proceedings of the National Academy of Sciences of the United Statesof America
    39. ROTHER RP; ROLLINS SA; FODOR WL; ALBRECHT JC; SETTER E; FLECKENSTEIN B; SQUINTO SP
      INHIBITION OF COMPLEMENT-MEDIATED CYTOLYSIS BY THE TERMINAL COMPLEMENT INHIBITOR OF HERPESVIRUS SAIMIRI

      Journal of virology
    40. FODOR WL; WILLIAMS BL; ROLLINS SA; MATIS LA; MADRI JA; VELANDER W; SQUINTO SP
      EXPRESSION OF A FUNCTIONAL HUMAN-COMPLEMENT INHIBITOR IN TRANSGENIC SWINE AS AN APPROACH TO ABROGATE XENOGENEIC ORGAN REJECTION

      Clinical research
    41. ROTHER RP; ROLLINS SA; MENNONE J; CHODERA A; FIDEL SA; BESSLER M; HILLMEN P; SQUINTO SP
      EXPRESSION OF RECOMBINANT TRANSMEMBRANE CD59 IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA B-CELLS CONFERS RESISTANCE TO HUMAN-COMPLEMENT

      Blood
    42. ROLLINS SA; EVANS MJ; JOHNSON KK; ELLIOT EA; SQUINTO SP; MATIS LA; ROTHER RP
      MOLECULAR AND FUNCTIONAL-ANALYSIS OF PORCINE E-SELECTIN REVEALS A POTENTIAL ROLE IN XENOGRAFT REJECTION

      Biochemical and biophysical research communications
    43. ROLLINS SA; EVANS MJ; JOHNSON KK; ELLIOT EA; SQUINTO SP; MATIS LA; ROTHER RP
      MOLECULAR AND FUNCTIONAL-ANALYSIS OF PORCINE E-SELECTIN REVEALS A POTENTIAL ROLE IN XENOGRAFT REJECTION

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 10:18:36